Compare Goldman Sachs Group Inc (GS) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goldman Sachs Group Inc vs Tempus AI — how do they compare? Goldman Sachs Group Inc trades at $1,093.47 (market cap $339.87B), while Tempus AI trades at $53.37 (market cap $10.28B). The key difference: Goldman Sachs Group Inc is far larger — about 33.1× Tempus AI's market cap, and Goldman Sachs Group Inc pays a 1.56% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| GS | TEM | |
|---|---|---|
Market Cap | $339.87B | $10.28B |
Volume | 2,592,735 | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $1.15K | $103.25 |
52-Week Low | $700.41 | $42.37 |
Dividend Yield | 1.56% | — |
Enterprise Value | — | $10.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Goldman Sachs (GS) trades at $1,140, up 9.0% over 24 hours, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $20.98 versus $14.47, and revenue growth from $58.28B in 2025 to $60.4B projected for 2026. Recent news highlights Goldman's role in leading high-profile IPOs including Anthropic, signaling strong investment banking pipeline strength.
Outlook remains positive with analyst consensus price target of $1,140K and 40% buy ratings, though RSI levels suggest potential near-term overbought conditions. Key risks include volatile cash flow patterns and high leverage, while institutional sentiment supports continued growth from M&A activity and AI-driven market opportunities.
Tempus AI (TEM) trades at $53.69, down 8.39% over 24 hours, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth ($1.27B in 2025) and consistent earnings beats, but remains unprofitable with negative net income margins (-22.2%). Recent news highlights AI deployment in healthcare systems and FDA clearances, supporting its data-driven healthcare platform.
The outlook balances high-growth potential in AI healthcare data against persistent profitability challenges. Analyst consensus is bullish with a $68.50 price target, but investors face risks from ongoing cash burn, competitive pressures, and execution hurdles as the company scales its platform toward sustainable margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
